VOR
Vor Biopharma Inc
18.70$
+3.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 73.7% | 67.1% | 66.9% | 63.7% | 58.0% | 67.5% | 59.3% | 99.8% | 97.9% | 98.7% | 98.8% | 98.8% | |
| 20.2% | 14.9% | 26.9% | 53.7% | 45.5% | 57.4% | 45.8% | 94.0% | 91.0% | 85.4% | 33.5% | 22.4% | |
| 71.8% | 65.4% | 64.3% | 60.7% | 54.1% | 64.3% | 54.9% | 98.8% | 96.7% | 98.1% | 97.0% | 96.9% | |
| 21.6% | 28.2% | 26.3% | 30.7% | 37.1% | 32.4% | 39.6% | 833.2% | 1,362.8% | 135.4% | 129.7% | 141.6% | |
| 6.9% | 7.4% | 7.9% | 9.7% | 12.4% | 13.0% | 15.3% | 28.6% | 10.7% | 5.4% | 3.2% | 5.2% | |
| 1.7% | 1.8% | 2.4% | 2.9% | 3.6% | 2.9% | 3.9% | – | 0.1% | 0.1% | 0.1% | 0.1% | |
| 0.6% | 0.4% | 1.4% | 1.4% | 1.1% | 1.1% | 3.4% | 0.3% | 0.5% | 1.1% | 0.2% | 0.8% | |
| 78.4% | 71.8% | 73.7% | 69.3% | 62.9% | 67.6% | 60.4% | -733.2% | -1,262.8% | -35.4% | -29.7% | -41.6% | |
| -140.7% | -162.1% | -222.0% | -281.6% | -367.5% | -319.8% | -447.8% | -1,004.6% | -1,631.8% | -248.4% | -270.9% | -298.4% | |
| 1.5% | 1.6% | 2.0% | 2.4% | 3.0% | 2.4% | 5.7% | 3.0% | 3.8% | 2.1% | 0.1% | 11.3% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.